Postmenopausal hormone replacement therapy: endometrial and breast effects.

Area of Science:

• Endocrinology
• Gynecologic Oncology
• Pathology

Background:

• Hormone replacement therapy (HRT) has a long history, originating in the late 1800s with animal ovarian extracts.
• Widespread adoption of synthetic hormones led to extensive HRT use among postmenopausal women globally by the late 20th century.
• Approximately 33-50% of postmenopausal women in the US and Europe used HRT by the late 1900s.

Purpose of the Study:

• To review the evidence regarding the effects of hormone replacement therapy (HRT) on the endometrium and breast.
• To emphasize the pathologic changes associated with HRT use in these tissues.

Main Methods:

• Review of existing scientific literature and clinical evidence.
• Analysis of studies linking HRT to specific cancer types.
• Focus on pathological alterations in endometrial and breast tissues.

Main Results:

• Estrogen-only HRT was associated with an increased rate of endometrial carcinoma.
• Combined estrogen and progestin HRT was linked to an increased breast cancer rate.
• These findings significantly altered the clinical use of HRT.

Conclusions:

• The historical use of HRT has been significantly impacted by evidence of increased cancer risks.
• Understanding the pathologic effects on the endometrium and breast is crucial for evaluating HRT's safety and efficacy.
• Further research is needed to clarify the complex relationship between HRT and cancer development.